Search NLS News

The global Biomodex business reached a total turnover of EUR 2.2 million in 2022. Biomodex specializes in biorealistic 3D printing and flow systems for interventional procedures, with a platform geared towards clinical use and patient-specific simulation. As part of the acquisition, Mentice will also retain key employees of Biomodex. “Biomodex is truly a quality product […]

Pfizer Denmark, Pharmadanmark and the Novo Nordisk Foundation have initiated the alliance and aim to prevent the growing spread of antimicrobial resistance (AMR). “The challenge of antimicrobial resistance cannot be solved by one country alone and requires a global effort. Denmark can play an important role in this by establishing significant initiatives that can inspire […]

Moungi Bawendi, a professor at the Massachusetts Institute of Technology (MIT) was awarded the Nobel Prize in Chemistry 2023 for his fundamental research on quantum dots, the nanoparticles that hold immense potential for a wide range of applications.

BioInvent International has presented the first clinical data from a Phase 1/2a trial of its second FcyRIIB-blocking antibody BI-1607. BioInvent pipeline currently includes five drug candidates progressing through six clinical trials. The Phase 1 data The Phase 1 data covered 18 patients treated at doses ranging from 75 mg up to 900 mg flat dose. […]

During preparations for the construction of two new cleanroom facilities, NorthX Biologics, a leading Swedish biological drug manufacturer and process developer, reviewed its environmental monitoring and control procedures, and decided to switch to a new Vaisala system. During preparations for the construction of two new cleanroom facilities, NorthX Biologics, a leading Swedish biological drug manufacturer […]

The partnership is set to transform the way food allergies (including peanut allergy) are treated and will combine Camallergy’s therapies with OnDosis’ Dosage Manager device technology. The drug-device combination aims to address the challenges physicians face in offering oral immunotherapy, making the treatment more accessible for patients, the company states. Oral immunotherapy (OIT) is a […]

Scientific research demands years, sometimes a lifetime’s worth, of persistence. One of the 2023 Nobel Prize winners in Physiology or Medicine, Dr. Katalin Karikó, PhD, has shown more determination than most. Despite a series of setbacks, she forged ahead on messenger RNA research that contributed to a vaccine for the COVID-19 virus.

Herantis Pharma has carried out an offering of new shares in a directed share issue to institutional and other qualified investors. “We thank our existing shareholders, many of whom participated in this directed issue, for their continued support in developing HER-096 as a promising disease-modifying drug candidate for Parkinson’s disease. We are delighted to welcome […]

Mendus has entered into a collaboration with the Australasian Leukaemia & Lymphoma Group (ALLG) to conduct a Phase 2 clinical trial, evaluating its lead product candidate vididencel in combination with oral azacitidine (AZA) as a potential novel maintenance treatment in acute myeloid leukemia (AML). Mendus and ALLG expect to obtain all approvals required for the […]

The planned restructuring would result in an approximately 20-25% reduction in the current workforce and will result in approximately SEK 75-85 million in annual savings when implemented. The restructuring is subject to negotiation with relevant trade unions. While we firmly believe this initiative is a necessary action to help us deliver on our mission, it […]